| Factor Information | |
|---|---|
| Data ID | 3176 |
| Factor | combined with atrial fibrillation (AF) type of tachyarrhythmias |
| Description | tachyarrhythmias combined with AF was a predictor for treatment failure in response to sotalol |
| Biomarker | NA |
| Classification | Z (combined factor - combined factor) |
| Association | |
|---|---|
| Application | risk assessment and prognosis |
| Objective | The purpose of this study was to assess the efficacy and safety of sotalol for refractory tachyarrhythmias in patients with CHD. |
| p Value | 0.0053 |
| OR | 18.3 |
| Conclusion | Tachyarrhythmias combined with AF was a predictor for treatment failure in response to sotalol. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 659 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF, PA/TOF/EA/UVH/TGA/PA/ccTGA |
| Reference | |
|---|---|
| PMID | 18931451 |
| Year | 2008 |
| Title | Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease |
| Sample | ||
|---|---|---|
| Population | adolescent and adult | |
| Source | patients' data | |
| Region | Suita, Japan | |
| Method | 1-way ANOVA | |
| Race | Japanese | |
| Disease History | N/A | |
| Treatment History | surgery | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | N/A | N/A |
| Age | mean age=23±12 years(range: 0.1-42 years) | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | total=5(11%), complete control=0, partial control=1(7%), failure=4(36%) | N/A |
